Waiting List Analysis
RTT REMOVALS
Identify pathways inflating the RTT PTL so that they can be removed
PRIORITY PATIENTS
Identify patients on the
Non-RTT (Follow-Up) waiting list who may be at risk of clinical harm or whose care should be prioritised
APPOINTMENTS OF LIMITED CLINICAL VALUE
Identify patients on the Non-RTT (Follow-Up) waiting list whose appointments may be of limited clinical value
SAMPLE VALIDATION COHORTS
Support the Trust in creating sample validation cohorts
Source Group's waiting list analysis is a key component of our Identify, Rectify, Prevent methodology.
One of the key objectives of the identify methodology is to highlight patients at potential clinical risk as well as those whose care should be prioritised. In addition, identifying patients that should be removed from the waiting list e.g., a patient on the RTT waiting list who has had first definitive treatment, or a patient on the follow-up waiting list who does not require the activity for which they are waiting.
This is achieved via analysis of the Trust waiting list, be this the RTT or Non-RTT waiting list. This analysis is conducted using both a machine learning algorithm and logically derived criteria to identify the records most likely to require the Trusts attention. This drastically reduces the amount of validation resources required to achieve the same end result, significantly reducing Trust spend and the timeframe for the exercise.
The analysis is based upon key NHS data dictionary fields, meaning a data extract can be generated rapidly with minimal strain on the Trust information staff.
If you would like to discuss how we can support your Trust through analysis of your RTT or Non-RTT (Follow-up) waiting list. Please contact us.
137
Trust's waiting lists analysed
Source Group's waiting list analysis used to support 2 NHSEI national validation programmes
2
300 %
increase in PTL removal rate when utilising targeted validation
“Clear PTL has proved to be a really useful tool for identifying pathways that require our attention, allowing us to focus our validation efforts. It has supported us in keeping our resource levels at a balance, freeing up time for our teams to address the root cause issues, such as developing and delivering targeting RTT training. We are looking forward to further capitalising on the intelligence provided by Clear PTL to generate in-depth reports exploring changes in our PTL over-time, supporting us in improving the accuracy of our PTL even further”
Jo Young
Head of Planned Access & Central Administration Bureau
Bradford Teaching Hospitals NHS Foundation Trust